Who
John P. Gandolfo
Director
Company insider
Files Form 4 as: Director, electroCore; Director, Oragenics; Chief Financial Officer, Hyperion DeFi; Director and Other, Odyssey Health; CFO, Xtant Medical Holdings.
In numbers
- Trades disclosed
- 43
- Buys
- 8
- Sells
- 0
- Bought
- $95K
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 3
- First trade
- 2 May 2011
- Last trade
- 9 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Sep 2026filed 10 Sep 2026 | ECOR electroCoreMedical Devices | SEC FORM 4 Code A | —11,123 at $0.00 | filing |
| 9 Sep 2026filed 10 Sep 2026 | ECOR electroCoreMedical Devices | SEC FORM 4 Code A | —11,123 at $0.00 | filing |
| 11 Dec 2025filed 15 Dec 2025 | OGEN Oragenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 2 Sep 2025filed 4 Sep 2025 | ECOR electroCoreMedical Devices | SEC FORM 4 Code A | —19,011 at $0.00 | filing |
| 23 May 2025filed 27 May 2025 | ECOR electroCoreMedical Devices | SEC FORM 4 Bought | $9,0181,800 at $5.01 | filing |
| 19 Sep 2024filed 20 Sep 2024 | OGEN Oragenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 3 Sep 2024filed 5 Sep 2024 | ECOR electroCoreMedical Devices | SEC FORM 4 Code A | —16,583 at $0.00 | filing |
| 13 Jun 2024filed 17 Jun 2024 | ECOR electroCoreMedical Devices | SEC FORM 4 Bought | $6,4301,000 at $6.43 | filing |
| 12 Feb 2024filed 14 Feb 2024 | HYPD Hyperion DeFioption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 10 Jan 2024filed 16 Jan 2024 | Odyssey Healthoption or derivative | SEC FORM 4 Code D | $135K1,500,000 at $0.09 | filing |
| 10 Jan 2024filed 16 Jan 2024 | Odyssey Health | SEC FORM 4 Code A | $135K1,500,000 at $0.09 | filing |
| 4 Oct 2023filed 6 Oct 2023 | OGEN Oragenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,102 at $0.00 | filing |
| 4 Aug 2023filed 8 Aug 2023 | ECOR electroCoreMedical Devices | SEC FORM 4 Code A | —21,739 at $0.00 | filing |
| 31 May 2023filed 31 May 2023 | HYPD Hyperion DeFiBiotechnology | SEC FORM 4 Bought | $5,5802,000 at $2.79 | filing |
| 17 Jan 2023filed 18 Jan 2023 | HYPD Hyperion DeFioption or derivative · Biotechnology | SEC FORM 4 Code A | —68,235 at $0.00 | filing |
| 12 Jan 2023filed 13 Jan 2023 | Odyssey Healthoption or derivative | SEC FORM 4 Code A | $150K500,000 at $0.30 | filing |
| 2 Dec 2022filed 6 Dec 2022 | ECOR electroCoreMedical Devices | SEC FORM 4 Code A | —205,987 at $0.00 | filing |
| 19 May 2022filed 8 Jun 2022 | Odyssey Healthoption or derivative | SEC FORM 4 Code A | $75K250,000 at $0.30 | filing |
| 19 May 2022filed 8 Jun 2022 | Odyssey Healthoption or derivative | SEC FORM 4 Code A | $75K250,000 at $0.30 | filing |
| 17 May 2022filed 18 May 2022 | ECOR electroCoreMedical Devices | SEC FORM 4 Bought | $5,40015,000 at $0.36 | filing |
News
Hyperion DeFi Schedules Third Quarter Earnings Call for Thursday, November 12 at 8:00 a.m. ETHYPD · manilatimes.net · 19 Oct 2026Enovis (NYSE:ENOV) and electroCore (NASDAQ:ECOR) Head to Head SurveyECOR · themarketsdaily.com · 11 Oct 2026Enovis (NYSE:ENOV) versus electroCore (NASDAQ:ECOR) Financial ContrastECOR · tickerreport.com · 9 Oct 2026
0 headlines in the last 90 days name John P. Gandolfo; 3 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.